well they couldn't even get a BV gel approved in the US with a successful clinical trial, so I think they know they will be up against it with only lab data.
No traction in India, so approval there means nothing with noone interested in distributing the product.
UK they tried and got the products pulled off the shelves for labelling and still haven't sorted that mess out.
Australia they got fined by the TGA, and are still working on labelling.
Beggars can't be choosers, so if there is someone on the other end willing to distribute the product in Vietnam.. then that is where the focus will be.
The sad thing is a company that was meant to be valued on its DEP platform seems to have very little to share on it after all these years. Lets hope the release of the phase 2 data in the coming weeks/months is worth the wait, as I feel like we have already been told what the highlights of the trial have been thus far... so I don't think rehashing the same news will do much. My hopes lie in a big partnership coming from the phase 2 trial results... if that doesn't eventuate, then I don't think that market will be very happy.
Ann: VIRALEZE distribution in Saudi Arabia - supplementary info, page-55
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
